The expansion of clinical research focused on cardiovascular, metabolic, and inflammatory conditions is creating new opportunities for the plasminogen activator inhibitor market. Researchers are increasingly examining PAI-related biomarkers and therapeutic targets to improve understanding of disease mechanisms and treatment possibilities. Market Overview The Plasminogen Activator...